SEOUL, South Korea, Oct. 10, 2023 /PRNewswire/ -- CanariaBio Inc. and Hikma MENA FZE, part of Hikma...
The investigational monoclonal antibody becomes the first to target Mucin 1 (MUC1) and receive this...
